Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (61-70 of 273) with videos related to

Pageof 28
Sort By:
British Journal of Cancer|October 3, 1999
The risk of angiosarcoma following primary breast cancerW Cozen, L Bernstein, F Wang, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1990
HER-2/neu oncogene expression and DNA ploidy analysis in breast cancerS S Bacus, J W Bacus, D J Slamon, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2014
Characterization of HER2 status by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC)Oliver A Press, Roberta Guzman, Monica Cervantes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1985
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assaysM F Press, J A Holt, A L Herbst, et al.
The Journal of Maternal-Fetal Medicine|January 19, 2002
Teenage pregnancy: risk factors for adverse perinatal outcomeL Gortzak-Uzan, M Hallak, F Press, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancerHuiyan Ma, Jianning Luo, Michael F Press, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
P7 antigen expression in human breast cancerXiaowei Yang, Susan Groshen, Silvia C Formenti, et al.
Cancer|November 6, 2003
Lifetime recreational exercise activity and risk of breast carcinoma in situAlpa V Patel, Michael F Press, Kathleen Meeske, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerationsGuido Sauter, James Lee, John M S Bartlett, et al.
Progress in Clinical and Biological Research|January 1, 1990
HER-2/neu oncogene amplification and expression in breast and ovarian cancersM F Press, L A Jones, W Godolphin, et al.
Pageof 28

Showing results (61-70 of 273) with videos related to

Sort By:
Pageof 28
British Journal of Cancer|October 3, 1999
The risk of angiosarcoma following primary breast cancerW Cozen, L Bernstein, F Wang, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1990
HER-2/neu oncogene expression and DNA ploidy analysis in breast cancerS S Bacus, J W Bacus, D J Slamon, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2014
Characterization of HER2 status by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC)Oliver A Press, Roberta Guzman, Monica Cervantes, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1985
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assaysM F Press, J A Holt, A L Herbst, et al.
The Journal of Maternal-Fetal Medicine|January 19, 2002
Teenage pregnancy: risk factors for adverse perinatal outcomeL Gortzak-Uzan, M Hallak, F Press, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancerHuiyan Ma, Jianning Luo, Michael F Press, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
P7 antigen expression in human breast cancerXiaowei Yang, Susan Groshen, Silvia C Formenti, et al.
Cancer|November 6, 2003
Lifetime recreational exercise activity and risk of breast carcinoma in situAlpa V Patel, Michael F Press, Kathleen Meeske, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerationsGuido Sauter, James Lee, John M S Bartlett, et al.
Progress in Clinical and Biological Research|January 1, 1990
HER-2/neu oncogene amplification and expression in breast and ovarian cancersM F Press, L A Jones, W Godolphin, et al.
Pageof 28